pentobarbital will decrease the level or influence of guanfacine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Potent or moderate CYP3A4 inducers appreciably decrease guanfacine plasma concentrations and elimination 50 percent-lifetime.pentobarbital will minimize the extent or influence of disopyramide